| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 29,29% | 36,19% | -15,03% | · |
| SCHRODER ISF US SMALLER COMPANIES IMPACT I ACC USD | RVI USA SMALL/MID CAP | 29,29% | 61,00% | 48,39% | 181,46% |
| AMUNDI JPX-NIKKEI 400 UCITS ETF DAILY EUR HEDGED CAP | RVI JAPÓN | 29,28% | 93,74% | 133,50% | · |
| IMGP DBI MANAGED FUTURES R EUR ETF | RENT. ABSOLUTA. | 29,27% | · | · | · |
| PICTET - EMERGING MARKETS INDEX JS USD | RVI EMERGENTES | 29,27% | 75,80% | 51,89% | · |
| WELLINGTON EMERGING MARKETS RESEARCH EQUITY N USD ACC | RVI EMERGENTES | 29,27% | 75,90% | 37,93% | 118,07% |
| BNP PARIBAS JAPAN EQUITY CLASSIC JPY DIS | RVI JAPÓN | 29,26% | 62,18% | 56,22% | 90,52% |
| CHALLENGE PACIFIC EQUITY L-A | RVI ASIA PACÍFICO | 29,26% | 60,12% | 38,63% | 79,25% |
| PICTET - EMERGING MARKETS INDEX P EUR | RVI EMERGENTES | 29,26% | 73,65% | 48,49% | 121,63% |
| T.ROWE GLOBAL VALUE EQUITY FUND IDS1 (GBP) | RVI GLOBAL VALOR | 29,26% | · | · | · |
